Jespersen, C. G., Nørgaard, M. & Borre, M. (2013).
Reply to C. Mary Schooling, Grace Sembajwe, and Ilir Agaliu's Letter to the Editor re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.02.002.
European Urology (Italian Edition),
64(3), e61.
https://doi.org/10.1016/j.eururo.2013.04.016
Nordentoft, I. K., Lamy, P., Birkenkamp-Demtröder, K., Vang, S., Reinert, T., Hedegaard, J., Thorsen, K., Fristrup, N., Borre, M., Andersen, L. D., Pedersen, J. S. & Ørntoft, T. F. (2013).
Whole genome and transcriptome analysis reveals novel genomic alterations in bladder cancer. Poster session presented at American Association for Cancer Research, Washington, DC, United States.
Keller, A. K., Lassen, C. K., Møldrup, U., Bibby, B. M. & Jespersen, B. (2013).
Messengers of renal graft quality during warm and cold ischemia - a porcine microdialysis study.
Transplantation Proceedings,
45(3), 1172-7.
Røder, M. A., Brasso, K., Christensen, I. J., Johansen, J.
, Langkilde, N. C., Hvarness, H., Carlsson, S., Jakobsen, H.
, Borre, M. & Iversen, P. (2013).
Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study.
B J U International (Print).
https://doi.org/10.1111/bju.12065
Christensen, J. S., Asklund, C., Skakkebæk, N. E., Jørgensen, N., Andersen, H. R.
, Jørgensen, T. M., Olsen, L. H., Høyer, A. P., Moesgaard, J., Thorup, J. M. & Jensen, T. K. (2013).
Association between organic dietary choice during pregnancy and hypospadias in offspring: A study of mothers of 306 boys operated for hypospadias.
The Journal of Urology,
189(3), 1077-1082.
https://doi.org/10.1016/j.juro.2012.09.116
Wagenlehner, F. M. E., van Oostrum, E., Tenke, P., Tandogdu, Z., Çek, M., Grabe, M., Wullt, B., Pickard, R., Naber, K. G., Pilatz, A., Weidner, W.
, Johansen, T. E. B. & GPIU investigators (2013).
Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.
European Urology,
63(3), 521-7.
https://doi.org/10.1016/j.eururo.2012.06.003
Wagenlehner, F., van Oostrum, E., Tenke, P., Tandogdu, Z., Cek, M., Grabe, M., Wullt, B., Pickard, R., Naber, K. G., Pilatz, A., Weidner, W.
& Johansen, T. E. B. (2013).
Reply from Authors re.: Riccardo Bartoletti, Tommaso Cai.Prostate Biopsies Should Be Performed According to a Standard of Care.
European Urology,
63(3), 529-30. Article 63, 3.
https://doi.org/10.1016/j.eururo.2012.07.037
Fristrup, N., Birkenkamp-Demtröder, K., Reinert, T., Sanchez-Carbayo, M., Segersten, U., Malmström, P.-U., Palou, J., Alvarez-Múgica, M., Pan, C.-C.
, Ulhøi, B. P., Borre, M., Ørntoft, T. F. & Andersen, L. D. (2013).
Multicenter validation of Cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle invasive bladder cancer.
American Journal of Pathology,
182(2), 339-349.
https://doi.org/10.1016/j.ajpath.2012.10.017
Ostenfeld, M. S., Jeppesen, D. K., Laurberg, J. R., Boysen, A., Howard, K., Christensen, E. I., Morth, P., Bui, K. H., Theodorescu, D.
, Jensen, J. B., Borre, M., Dyrskjøt, L. & Ørntoft, T. F. (2013).
Keystone Symposia "ncRNAs in Development and Cancer", Vancouver, Canada: Increased release of exosomes and export of invasion-modulating miRNAs miR921, -23b, -and -224 from metastatic urothelial carcinoma cells.
Sørensen, K. D., Abildgaard, M. O.
, Haldrup, C., Ulhøi, B. P., Kristensen, H., Strand, S. H., Parker, C., Høyer, S.
, Borre, M. & Ørntoft, T. F. (2013).
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer.
B J C, (108), 420-428.
https://doi.org/10.1038/bjc.2012.549
Birkenkamp-Demtröder, K., Mansilla, F., Andersen, L. D., Thorsen, K., Fristrup, N., Brems-Eskildsen, A. S., Madsen, P. P., Sørensen, K. D., Borre, M. & Ørntoft, T. F. (2013).
TOX3 (TNRC9) overexpression in bladder cancer cells decreases cellular proliferation and triggers an interferon-like response.
Journal of Molecular Biomarkers & Diagnosis,
4(1), 1-11.
https://doi.org/10.4172/2155-9929.1000140
Schepeler, T., Lamy, P., Hvidberg, V., Laurberg, J. R., Fristrup, N., Reinert, T., Bartkova, J., Tropia, L., Bartek, J., Halazonetis, T. D., Pan, C.-C.
, Borre, M., Andersen, L. D. & Orntoft, T. F. (2013).
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.
Oncogene,
32, 3577-3586.
https://doi.org/10.1038/onc.2012.381
Amin Al Olama, A., Kote-Jarai, Z., Schumacher, F. R., Wiklund, F., Berndt, S. I., Benlloch, S., Giles, G. G., Severi, G., Neal, D. E., Hamdy, F. C., Donovan, J. L., Hunter, D. J., Henderson, B. E., Thun, M. J., Gaziano, M., Giovannucci, E. L., Siddiq, A., Travis, R. C., Cox, D. G. ... The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology (2013).
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Human Molecular Genetics.
https://doi.org/10.1093/hmg/dds425
Jakobsen, J. K., Krarup, K. P., Sommer, P., Nerstrøm, H.
& Jensen, J. B. (2013).
An active sex life at the time of diagnosis is associated with favorable disease charcteristics and prognosis in penile cancer. Abstract from NUF Congress 2013, Sandefjord, Norway.
Bobkov, Y.
, Jakobsen, J. K., Agerbaek, M., Nerstrøm, H., Sommer, P. & Petersen, P. M. (2013).
Chemotherapy and radiation therapy in penile cancer in Denmark: Ten year's experience from two centres.
Rasmussen, M. M., Krogh, K., Clemmensen, D., Bluhme, H., Rawashdeh, Y. F. H. & Christensen, P. (2013).
Colorectal transport during defecation in subjects with supraconal spinal cord injury.
Spinal Cord,
51(9).
Nguyen-Nielsen, M., Nørgaard, M., Jacobsen, J. B., Borre, M., Thomsen, R. W. & Søgaard, M. (2013).
Comorbidity and survival of Danish prostate cancer patients from 2000-2011: a population-based cohort study.
Clinical Epidemiology,
5(Suppl 1), 47-55.
https://doi.org/10.2147/CLEP.S47153
Madsen, M. G., Nørregaard, R., Palmfeldt, J., Olsen, L. H., Frøkiær, J. & Jørgensen, T. M. (2013).
Epidermal growth factor and monocyte chemotactic peptide-1: Potential biomarkers of urinary tract obstruction in children with hydronephrosis.
Journal of Pediatric Urology,
9(6 (Part A)), 838–845.
https://doi.org/10.1016/j.jpurol.2012.11.011
Keller, A. K., Jørgensen, T. M., Vittrup, D. M., Kjerkegaard, U. K.
, Jespersen, B., Krag, S. R. P.
, Bibby, B. M. & Stolle, L. B. (2013).
Fast Detection of Renal Ischemia in Transplanted Kidneys With Delayed Graft Function-An Experimental Study.
Transplantation,
95(2), 275-279.
https://doi.org/10.1097/TP.0b013e318276a1c8
Secher, N., Søndergaard, P., Ravlo, K., Sølling, C., Granfeldt, A., Barklin, A., Wogensen, L., Keller, A. K., Møldrup, U., Østraat, Ø., Jørgensen, T. M., Jespersen, B. & Tønnesen, E. K. (2013).
Inflammatory effects of remote ischaemic conditioning in a porcine kidney transplantation model.
Jakobsen, J. K., Krarup, K. P., Sommer, P., Nerstrøm, H.
& Jensen, J. B. (2013).
Sources of delay to two penile cancer referral centres in Denmark. Abstract from NUF Congress 2013, Sandefjord, Norway.
Cockle-Hearne, J., Charnay-Sonnek, F., Denis, L., Fernandez-Ortega, P., Kav, S., Kelly, D., Leonard, K., Van Muilekom, E.
, Jensen, B. T. & Faithfull, S. (2013).
Supportive care needs of men with prostate cancer: A european survey for the prostate cancer education project (PrEP).
European Journal of Oncology Nursing, 14-15. Article vol. 16, suppl.
Borre, M. (2013).
Urologi. In H. R. Ivarsen & A. Aziz (Eds.),
Sygdomslære for sundhedsprofessionelle (1 ed., Vol. 1, pp. 127-142). Gads Forlag.
Maniecki, M. B., Etzerodt, A., Ulhøi, B. P., Steiniche, T., Borre, M., Andersen, L. D., Orntoft, T. F., Moestrup, S. K. & Møller, H. J. (2012).
Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
International Journal of Cancer,
131(10), 2320-2331.
https://doi.org/10.1002/ijc.27506
Jensen, M. S., Snerum, T. M.
, Olsen, L. H., Thulstrup, A. M., Bonde, J. P., Olsen, J. & Henriksen, T. B. (2012).
Accuracy of Cryptorchidism Diagnoses and Corrective Surgical Treatment Registration in the Danish National Patient Registry. Journal of Urology,
188(4), 1324-1329.
Andersen, L. D., Reinert, T., Novoradovsky, A., Zuiverloon, T. C. M., Beukers, W., Zwarthoff, E., Malats, N., Real, F. X., Segersten, U., Malmström, P.-U., Knowles, M., Hurst, C., Sorge, J.
, Borre, M. & Orntoft, T. F. (2012).
Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR.
B J C, (107), 1392-1398.
https://doi.org/10.1038/bjc.2012.412
Nordentoft, I. K., Birkenkamp-Demtröder, K., Agerbæk, M., Theodorescu, D.
, Ostenfeld, M. S., Hartmann, A.
, Borre, M., Ørntoft, T. F. & Andersen, L. D. (2012).
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer.
BMC Medical Genomics,
5(40), 1-11.
https://doi.org/10.1186/1755-8794-5-40
Pandha, H.
, Sørensen, K. D., Ørntoft, T. F., Langley, S., Hoyer, S.
, Borre, M. & Morgan, R. (2012).
Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.
B J U International (Print),
110(6 Pt B), E287-92.
https://doi.org/10.1111/j.1464-410X.2012.11208.x
Bentzon, D. N., Nyegaard, M., Børglum, A., Ørntoft, T. F., Borre, M. & Dalsgaard Sørensen, K. (2012).
Replication of Prostate Cancer Risk Variants in a Danish Case-Control Association Study.
Open Journal of Urology,
2(2), 45-54.
https://doi.org/10.4236/oju.2012.22009
Fristrup, N., Birkenkamp-Demtröder, K., Ulhøi, B. P., Mansilla, F., Sanchez-Carbayo, M., Segersten, U., Malmström, P.-U., Palou, J., Alvarez-Múgica, M., Pan, C.-C.
, Borre, M., Ørntoft, T. F. & Andersen, L. D. (2012).
A panel of prognostic protein markers for progression in non-muscle invasive bladder cancer - a multicenter tissue microarray validation study.
https://doi.org/10.1158/1538-7445.AM2012-3657
Fristrup, N., Ulhøi, B. P., Birkenkamp-Demtröder, K., Mansilla, F., Hartmann, A., Sanchez-Carbayo, M.
, Borre, M., Ørntoft, T. F. & Andersen, L. D. (2012).
Cathepsin E, Maspin, PLK1, and Survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.
https://doi.org/10.1158/1538-7445.AM2012-3656